STA’s expertise in process development and manufacturing was employed by our client for an expensive advanced intermediate. With an initial unit cost of > $3k/kg, our client wanted to develop a cost-efficient and scalable advanced intermediate process to improve their overall API’s cost of goods.
Our team evaluated the use of cheaper, more readily-accessible raw materials during extensive process research and development studies and led to the development of a cost-efficient and scalable process.
The manufacturing process was successfully transferred and launched in our commercial manufacturing plant and resulted in a higher quality product with a unit cost of < $1.4k/kg (i.e., > 50% price reduction). To date, STA has successfully delivered over 45 MT of this material to our client. Over the past three years, we have invested a total of $40 million in capital investment to expand our commercial manufacturing infrastructure and help our clients meet potential market demands.
Flexible manufacturing assets consisting of a total GMP capacity of 234m³ with multi-purpose reactors ranging from 3,000L to 20,000L, support projects through their commercial lifecycle.
Our FDA approved commercial plants are well equipped and experienced to scale up all types of reactions producing multi tonne quantities of APIs and advance intermediates. With our highly experienced project management and dedicated client service team, we deliver assurance of supply to our customers.
All of STA's manufacturing sites operate 24/7, with on-site process chemistry, process engineer, and analytical support providing the foundations of our assurance of supply to you.
End-to-end process R&D and API manufacturing capabilities, ensuring a seamless transfer of know-how and scale, as programs advance from preclinical to commercial.
Building on the foundations of the WuXi business, we understand from personal experience what you need and expect from a service provider.Contact us